Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Johnson

Showing results (121-130 of 221) with videos related to

Pageof 23
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumabAlan B Sandler, Joan H Schiller, Robert Gray, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2010
Sex differences in outcome with bevacizumab therapy: analysis of patients with advanced-stage non-small cell lung cancer treated with or without bevacizumab in combination with paclitaxel and carboplatin in the Eastern Cooperative Oncology Group Trial 4599Julie R Brahmer, Suzanne E Dahlberg, Robert J Gray, et al.
Oncology Reports|April 12, 2011
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancerJill M Kolesar, Suzanne E Dahlberg, Sharon Marsh, et al.
Gastrointestinal Endoscopy|November 26, 2016
Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screeningDavid H Johnson, John B Kisiel, Kelli N Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinomaGirum L Lemma, Ju-Whei Lee, Seena C Aisner, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|September 15, 2015
Burrowing Owls, Pulex irritans, and PlagueJames R Belthoff, Scott A Bernhardt, Christopher L Ball, et al.
Clinical Lung Cancer|May 18, 2012
Identifying barriers associated with enrollment of patients with lung cancer into clinical trialsLeora Horn, Vicki L Keedy, Norma Campbell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2013
Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trialsSuzanne E Dahlberg, Joan H Schiller, Philip B Bonomi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With <i>Clostridium difficile</i> Infection: A Nationwide AnalysisArjun Gupta, Raseen Tariq, Ryan D Frank, et al.
Contemporary Clinical Trials|February 12, 2025
Brief computer MI to motivate sustained tobacco cessation following psychiatric hospital discharge: Study protocol for a randomized controlled trialRichard A Brown, Abigail Winskowicz, David H Johnson, et al.
Pageof 23

Showing results (121-130 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2009
Retrospective evaluation of the clinical and radiographic risk factors associated with severe pulmonary hemorrhage in first-line advanced, unresectable non-small-cell lung cancer treated with Carboplatin and Paclitaxel plus bevacizumabAlan B Sandler, Joan H Schiller, Robert Gray, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2010
Sex differences in outcome with bevacizumab therapy: analysis of patients with advanced-stage non-small cell lung cancer treated with or without bevacizumab in combination with paclitaxel and carboplatin in the Eastern Cooperative Oncology Group Trial 4599Julie R Brahmer, Suzanne E Dahlberg, Robert J Gray, et al.
Oncology Reports|April 12, 2011
The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancerJill M Kolesar, Suzanne E Dahlberg, Sharon Marsh, et al.
Gastrointestinal Endoscopy|November 26, 2016
Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screeningDavid H Johnson, John B Kisiel, Kelli N Burger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 20, 2011
Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinomaGirum L Lemma, Ju-Whei Lee, Seena C Aisner, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|September 15, 2015
Burrowing Owls, Pulex irritans, and PlagueJames R Belthoff, Scott A Bernhardt, Christopher L Ball, et al.
Clinical Lung Cancer|May 18, 2012
Identifying barriers associated with enrollment of patients with lung cancer into clinical trialsLeora Horn, Vicki L Keedy, Norma Campbell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 27, 2013
Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trialsSuzanne E Dahlberg, Joan H Schiller, Philip B Bonomi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Trends in the Incidence and Outcomes of Hospitalized Cancer Patients With <i>Clostridium difficile</i> Infection: A Nationwide AnalysisArjun Gupta, Raseen Tariq, Ryan D Frank, et al.
Contemporary Clinical Trials|February 12, 2025
Brief computer MI to motivate sustained tobacco cessation following psychiatric hospital discharge: Study protocol for a randomized controlled trialRichard A Brown, Abigail Winskowicz, David H Johnson, et al.
Pageof 23